Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms
about
PEComas: the past, the present and the futureCutaneous perivascular epithelioid cell tumors: A review on an infrequent neoplasmMalignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature reviewThe tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptakeA systematic review: perivascular epithelioid cell tumor of gastrointestinal tract.Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management.Malignant mesenteric perivascular epithelioid cell neoplasm presenting as an intra-abdominal fistula in a 49-year-old female.Angiomyolipoma have common mutations in TSC2 but no other common genetic eventsBlocking the mTOR pathway: a drug discovery perspective.The loss of tuberin promotes cell invasion through the ß-catenin pathwayMalignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.The off-label use of targeted therapies in sarcomas: the OUTC'S programFibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?Glucose deprivation in tuberous sclerosis complex-related tumors.A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review.Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications"Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.A Case Series & Review of Literature of Angiomyolipoma with Medical & Surgical PerspectiveSuccessful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm.Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.The TSC1-TSC2 complex is required for proper activation of mTOR complex 2Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.A 22-year-old female with invasive epithelioid angiomyolipoma and tumor thrombus into the inferior vena cava: case report and literature review.Perivascular epithelioid tumours (PEComas) of the gynaecological tractMalignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.Management of perivascular epithelioid cell tumor of the liver: A case report and review of the literature.PEComa: A Perivascular Epithelioid Cell Tumor in the Liver-A Case Report and Review of the Literature.Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature reviewNeoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).PEComa of the nose: report of a case with immunohistochemical and ultrustructural studies and a review of the literature.Therapeutic pipeline for soft-tissue sarcoma.Soft tissue tumors of uncertain origin.Recently characterized soft tissue tumors that bring biologic insight.Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.Regulation of TFEB and V-ATPases by mTORC1.Renal epithelioid angiomyolipoma: Histopathologic review, immunohistochemical evaluation and prognostic significance.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Malignant renal epithelioid angiomyolipoma: A case report and review of the literature.
P2860
Q24651969-5F15A737-7FE6-4785-B7F1-61B734F2FEB2Q26750555-8E0B8AB1-55D6-4A22-9A88-A31048EFD63EQ27030897-1ECBEDDB-4210-4C26-BE83-965804F2EA3EQ28512637-8C7FAAF4-5F22-4B01-8F54-CE61E7D5B6C8Q30248929-B446D0CC-4CF9-40D0-8858-E2504A9881A8Q30437122-5BAF78EE-62DB-42FA-8001-889D3FEF0260Q33993991-F870BEC8-0EDD-4F17-A10B-97ED3F0ECC96Q34031604-982289D7-C3A7-492A-8820-0E6C54DFDA34Q34172699-34761265-433A-4178-A026-EA64D143C9E2Q34269014-7DD0C77D-0B22-4550-B8F4-8ECC1B4EE354Q34371874-4D8F9C5B-C4D6-4459-B9DB-1B7BD63614F5Q34897996-CFA72679-601C-4395-B34C-0977907F5181Q35099876-D7CEC86E-8B6D-4D19-80C3-C4826245DA0AQ35560024-72536F8C-64E0-45FB-97E3-19CF330CFABDQ35569068-2C793FB4-852A-4209-ADFB-1F7C8A34436CQ35606985-98FD7632-A905-428A-AF2E-444505284CA4Q35955322-4F9E8D77-4531-486B-83F4-CE462A1136FFQ36095750-A6F2D0F9-E3D7-4CAA-867B-05F05DDFE407Q36163081-9B80E8FE-CC63-4DE0-8F93-9553CBC15F9AQ36403065-8216A907-1475-4BB2-ABAF-EE3685E76730Q36515965-5B0E555D-C50F-4A01-BB0D-FC94307A504BQ36572374-DF86BB77-78B6-47FC-9A77-3EB885C6E517Q36710799-F11D7AA0-C17D-480F-9209-1E71B5F52A49Q36735206-4F7B470B-095B-4A17-B22D-2CAB5A4DB04AQ37101170-66D38CB9-E022-4D1F-9872-E18C51BA0DACQ37173539-22992424-5EBE-4C91-A7E8-2173C5FA7585Q37325498-EC298E14-986A-427E-8AF3-40FE85B7D37FQ37388711-938770AA-97C2-4C0B-B2FB-AE3F46E0255DQ37478466-B6EDFDF8-4545-49CE-9271-434B7694C05DQ37582125-946A7CE0-61DF-467D-8167-371E08ACB70EQ37619835-F4ACA00A-3320-4385-A0EB-EF2DDF2284D1Q37631280-C50F45A1-D388-4850-9127-C087BB7F8BE7Q37931268-B9D1A7D5-AC00-4908-8A7E-A3660F1C7C26Q37993931-44A01374-AFD9-4F3D-91EA-3ABFA7649441Q38175314-D69EC752-5686-4768-9C26-50CC364E77F8Q38197031-A45EE3DB-01F4-4810-8BB9-2714D9A0745EQ38256715-E0C228FB-7858-400B-A053-0557FE428F74Q38410919-7FA059F9-ED9E-44E0-A746-065281BC114EQ38591828-D2BF0CA5-1BEA-438C-9510-8D3A36DA72BFQ38730796-697980E5-49B0-4351-BBAA-479FEF629C90
P2860
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of the mTOR pathway ...... lar epithelioid cell neoplasms
@en
Activation of the mTOR pathway ...... ar epithelioid cell neoplasms.
@nl
type
label
Activation of the mTOR pathway ...... lar epithelioid cell neoplasms
@en
Activation of the mTOR pathway ...... ar epithelioid cell neoplasms.
@nl
prefLabel
Activation of the mTOR pathway ...... lar epithelioid cell neoplasms
@en
Activation of the mTOR pathway ...... ar epithelioid cell neoplasms.
@nl
P2093
P2860
P1433
P1476
Activation of the mTOR pathway ...... lar epithelioid cell neoplasms
@en
P2093
Andrew L Folpe
Heidi Kenerson
Raymond S Yeung
Thomas K Takayama
P2860
P304
P356
10.1016/J.HUMPATH.2007.01.028
P407
P577
2007-05-22T00:00:00Z